Comparison of highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone use in patients undergoing in vitro fertilization with progestin-primed ovarian stimulation protocol: a single center retrospective analysis
Authors:
- 2 October 2024
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 310 (5) , 2657-2662
Abstract
Purpose Recently, progesterone has been used to prevent LH surge instead of GnRH analogues during ART treatments, which is known as progesterone-primed ovarian stimulation (PPOS) protocol. During ART treatment, highly purified human menopausal gonadotropin (HP-hMG) and recombinant follicle stimulating hormone (rFSH) are two of the agents used for stimulation of antral follicles. The aim of this study is to compare the efficacy and success of HP-hMG and rFSH agents in the ovarian stimulation step of the PPOS protocol, which has not been previously reported in the literature. Methods This retrospective study was conducted at a university hospital with patients who underwent IVF treatment using PPOS protocols in between January 2019 and July 2021. For ovarian stimulation, rFSH was used in group I and HP-hMG was used in group II. Mature oocyte ratio was the primary outcome, and live birth rate was the secondary outcome. Mann–Whitney and Chi-square tests were used for statistical analysis. All p values below 0.05 were considered significant. Results Total numbers of follicles, oocytes, MII, and 2PN numbers obtained were similar between the two groups. The fertilization rates were 66.7% in the rFSH group and 64.3% in the HP-hMG group (p > 0.05). The pregnancy rates were 53.5% and 46.7% in the rFSH and HP-hMG groups, respectively. There was no statistically significant difference between pregnancy, abortus, and live birth rates. Conclusion In this study, it is demonstrated that stimulation of oocytes with either rFSH or hMG in the PPOS protocol, which has been added to IVF treatment protocols in recent years, had no statistical difference regarding mature oocyte numbers and live birth rates between the two groups. These results are consistent with the previous literature which compared rFSH and hMG in GnRH agonist and antagonist protocols.Keywords
This publication has 22 references indexed in Scilit:
- Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysisArchives of Gynecology and Obstetrics, 2021
- Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injectionFertility and Sterility, 2020
- Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technologyFertility and Sterility, 2019
- Could larger diameter of 4th generation ceramic bearing increase the rate of squeaking after THA?Medicine, 2018
- Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a “freeze all” strategy: a randomized controlled dose-finding study of 100 mg versus 200 mgFertility and Sterility, 2017
- Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspectiveReproductive BioMedicine Online, 2011
- Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized studyHuman Reproduction, 2008
- Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVFHuman Reproduction, 2007
- Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trialHuman Reproduction, 2006
- Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transferFertility and Sterility, 2000